Corporate News     19-Jan-24
Shilpa Medicare receives German, EU authorization for Amifampridine Tablets
Shilpa Medicare has received Marketing Authorization from Germany, EU for Amifampridine Tablets, 10 mg under the National Procedure. Amifampridine is used as a drug, predominantly in the treatment of a number of rare muscle diseases. Specifically, Amifampridine is used to treat Lambert-Eaton myasthenic syndrome (LEMS), a rare autoimmune disease.

This product has sales of about 20 M USD in Europe. As on date, there is one other approved generic in the market.

Previous News
  Shilpa Medicare hits life high on submission of new drug application to USFDA
 ( Hot Pursuit - 04-Sep-24   15:24 )
  Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics
 ( Corporate News - 04-Sep-24   15:14 )
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
 ( Hot Pursuit - 05-Jul-24   14:52 )
  Shilpa Biologicals receives first international market approval for Adalimumab
 ( Corporate News - 23-Jul-24   17:41 )
  Indices trade with minor losses; bank shares under pressure
 ( Market Commentary - Mid-Session 24-Jul-24   11:32 )
  Shilpa Medicare to conduct AGM
 ( Corporate News - 16-Aug-24   10:54 )
  Indices trade with stellar gains; pharma stocks in demand
 ( Market Commentary - Mid-Session 05-Jun-24   12:33 )
  Shilpa Pharma Lifesciences' API unit in Raichur receives GMP Certification
 ( Corporate News - 23-Jul-24   17:27 )
  Shilpa Medicare reports consolidated net profit of Rs 24.50 crore in the March 2024 quarter
 ( Results - Announcements 23-May-24   17:15 )
  Shilpa Medicare spurts as arm files DMF with USFDA
 ( Hot Pursuit - 05-Jun-24   11:15 )
  Shilpa Biologicals files first Drug Master File of recombinant Human Albumin 20% with USFDA
 ( Corporate News - 04-Jun-24   18:10 )
Other Stories
  ITD Cementation India wins order of Rs 1,937 cr
  03-Oct-24   10:35
  NIIT Learning Systems allots 1,666 equity shares under ESOP
  03-Oct-24   10:30
  Ashoka Metcast to discuss results
  03-Oct-24   10:29
  Emerald Finance to declare Quarterly Result
  03-Oct-24   10:29
  Rhetan TMT schedules board meeting
  03-Oct-24   10:29
  Shrenik to table results
  03-Oct-24   10:29
  Universal Arts to declare Quarterly Result
  03-Oct-24   10:28
  Three M Paper Boards to conduct board meeting
  03-Oct-24   10:28
  Arkade Developers to declare Quarterly Result
  03-Oct-24   10:28
  Worth Investment & Trading Company announces board meeting date
  03-Oct-24   10:28
Back Top